PharmacoEconomics
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Guidelines for Economic Analysis of Pharmaceutical Products
PharmacoEconomics - Tập 3 - Trang 354-361 - 2012
Summary In Canada, provincial formulary review committees consider the
effectiveness, safety, and cost of products when they derive advice for each
Minister of Health. This article offers a draft set of guidelines for
pharmaceutical manufacturers making submissions which include economic
information, moving beyond a simple presentation of the unit price of the
pharmaceutical product (e.g. price pe...
Cost of Illness of Glaucoma
PharmacoEconomics - Tập 27 - Trang 189-198 - 2012
Cost-of-illness studies determine the total financial burden of a disease by
considering direct and indirect costs, including medication, diagnostics and
surgery. Studies of resource use and costs associated with primary open-angle
glaucoma have used varying methodologies. Most have focused on consumption of
healthcare resources at various stages of disease to anticipate costs. The
direct costs as...
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models
PharmacoEconomics - - 2017
Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure
PharmacoEconomics - Tập 29 - Trang 753-769 - 2012
Chronic heart failure (CHF) is a critical public health issue with increasing
effect on the healthcare budgets of developed countries. Various
decisionanalytic modelling approaches exist to estimate the cost effectiveness
of health technologies for CHF. We sought to systematically identify these
models and describe their structures. We performed a systematic literature
review in MEDLINE/PreMEDLINE...
A Meta-Analysis of Quality-of-Life Estimates for Stroke
PharmacoEconomics - Tập 21 - Trang 191-200 - 2012
Background: Researchers performing cost-effectiveness analyses often incorporate
quality-of-life (QOL) estimates. Objective: To aid analysts, we performed a
meta-analysis to estimate quality of life for minor, moderate, and major stroke
and assessed the relative importance of study design characteristics in
predicting the quality of life of patients with stroke. Methods: Through a
systematic searc...
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?
PharmacoEconomics - - 2023
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
PharmacoEconomics - Tập 19 - Trang 767-778 - 2012
Objective: The primary objective of this study was to estimate the cost
effectiveness of treating diabetic foot ulcers with becaplermin (Regranex®) plus
good wound care (GWC) compared with GWC alone in a variety of European
healthcare settings. A secondary objective was to analyse the effect of
different treatment practices on the economics of caring for diabetic foot
ulcers. Design and setting: M...
Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era
PharmacoEconomics - Tập 28 - Trang 17-34 - 2012
Despite the success of combination antiretroviral therapy (ART) in improving
clinical outcomes, treatment failure remains a significant challenge,
particularly for highly treatment-experienced patients. This review evaluates
current issues in the management of HIV-infected, treatment-experienced
patients. It may provide guidance in selecting active, tolerable drug
combinations that promote a reaso...
Tổng số: 2,573
- 1
- 2
- 3
- 4
- 5
- 6
- 10